These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 37345445)

  • 1. Methotrexate vs expectant management for treatment of tubal ectopic pregnancy: An individual participant data meta-analysis.
    Solangon SA; Van Wely M; Van Mello N; Mol BW; Ross JA; Jurkovic D
    Acta Obstet Gynecol Scand; 2023 Sep; 102(9):1159-1175. PubMed ID: 37345445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison.
    van Mello NM; Mol F; Verhoeve HR; van Wely M; Adriaanse AH; Boss EA; Dijkman AB; Bayram N; Emanuel MH; Friederich J; van der Leeuw-Harmsen L; Lips JP; Van Kessel MA; Ankum WM; van der Veen F; Mol BW; Hajenius PJ
    Hum Reprod; 2013 Jan; 28(1):60-7. PubMed ID: 23081873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose systemic methotrexate vs expectant management for treatment of tubal ectopic pregnancy: a placebo-controlled randomized trial.
    Jurkovic D; Memtsa M; Sawyer E; Donaldson AN; Jamil A; Schramm K; Sana Y; Otify M; Farahani L; Nunes N; Ambler G; Ross JA
    Ultrasound Obstet Gynecol; 2017 Feb; 49(2):171-176. PubMed ID: 27731538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for non-tubal ectopic pregnancy.
    Long Y; Zhu H; Hu Y; Shen L; Fu J; Huang W
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD011174. PubMed ID: 32609376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate versus expectant management in ectopic pregnancy: a meta-analysis.
    Naveed AK; Anjum MU; Hassan A; Mahmood SN
    Arch Gynecol Obstet; 2022 Mar; 305(3):547-553. PubMed ID: 34524502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The METEX study: methotrexate versus expectant management in women with ectopic pregnancy: a randomised controlled trial.
    van Mello NM; Mol F; Adriaanse AH; Boss EA; Dijkman AB; Doornbos JP; Emanuel MH; Friederich J; Leeuw-Harmsen Lv; Lips JP; van Santbrink EJ; Verhoeve HR; Visser H; Ankum WM; Veen Fv; Mol BW; Hajenius PJ
    BMC Womens Health; 2008 Jun; 8():10. PubMed ID: 18565217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expectant management of tubal pregnancies with human chorionic gonadotropin up to 2000 mIU/mL.
    Kugelman N; Cohen B; Yossef F; Margieh N; Regev N; Shani U; Bart Y
    Int J Gynaecol Obstet; 2024 Mar; 164(3):1094-1100. PubMed ID: 37776069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate vs placebo in early tubal ectopic pregnancy: a multi- centre double-blind randomised trial.
    Casikar I; Lu C; Reid S; Bignardi T; Mongelli M; Morris A; Wild R; Condous G
    Rev Recent Clin Trials; 2012 Aug; 7(3):238-43. PubMed ID: 22540910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis.
    Mol F; Mol BW; Ankum WM; van der Veen F; Hajenius PJ
    Hum Reprod Update; 2008; 14(4):309-19. PubMed ID: 18522946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of β-hCG values in prediction of the effectiveness of single dose methotrexate therapy in tubal ectopic pregnancy.
    Yıldız A; Bilge O
    Ginekol Pol; 2023; 94(4):303-308. PubMed ID: 35315015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of health-related quality of life in women with ectopic pregnancy or pregnancy of unknown location treated with systemic methotrexate or expectant management.
    van Mello NM; Mol F; Hajenius PJ; Ankum WM; Mol BW; van der Veen F; van Wely M
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():1-5. PubMed ID: 26125101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cut-off value of initial serum β-hCG level predicting a successful MTX therapy in tubal ectopic pregnancy: a retrospective cohort study.
    Helmy S; Bader Y; Pablik E; Tiringer D; Pils S; Laml T; Kölbl H; Koch M
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():175-80. PubMed ID: 24956362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictors of successful methotrexate treatment of tubal ectopic pregnancy.
    Abdelfattah-Arafa E; Abdussalam HF; Omar Saad M; El Ansari W
    J Obstet Gynaecol; 2024 Dec; 44(1):2361456. PubMed ID: 38864434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose versus two-dose administration of methotrexate for the treatment of ectopic pregnancy: a randomized controlled trial.
    Song T; Kim MK; Kim ML; Jung YW; Yun BS; Seong SJ
    Hum Reprod; 2016 Feb; 31(2):332-8. PubMed ID: 26701971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early (Days 1-4) post-treatment serum hCG level changes predict single-dose methotrexate treatment success in tubal ectopic pregnancy.
    Mackenzie SC; Moakes CA; Doust AM; Mol BW; Duncan WC; Tong S; Horne AW; Whitaker LHR
    Hum Reprod; 2023 Jul; 38(7):1261-1267. PubMed ID: 37178269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic accuracy of a novel methotrexate protocol for the resolution of tubal ectopic pregnancies.
    Leonardi M; Allison E; Lu C; Nadim B; Condous G
    Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():186-190. PubMed ID: 32126410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Day 1 to day 4 serum hCG change in predicting single-dose methotrexate treatment failure for tubal ectopic pregnancies.
    Goh A; Karine P; Kirby A; Williams C; Kapurubandara S
    Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():105-110. PubMed ID: 33113399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and human chorionic gonadotropin trends in patients with ruptured tubal ectopic pregnancies despite methotrexate treatment.
    Hutchinson AP; Pereira N; Chung ER; Shah NJ; Zeku M; Chung PH; Rosenwaks Z
    Gynecol Endocrinol; 2019 Jan; 35(1):49-52. PubMed ID: 30322280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 2-year reproductive outcomes of tubal ectopic pregnancies treated with surgery, methotrexate or expectant management.
    Fıratlıgil FB; Sucu S; Sucu ST; Ozkan MA; Reis YA; Dereli ML; Ozkan S; Engin-Ustun Y
    Arch Gynecol Obstet; 2024 Nov; 310(5):2561-2568. PubMed ID: 39331053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early prediction of methotrexate treatment outcome in tubal ectopic pregnancy based on days 0 and 4 human chorionic gonadotropin levels.
    Shatkin Hamish N; Wolf M; Tendler R; Sharon A; Bornstein J; Odeh M
    J Obstet Gynaecol Res; 2020 Jul; 46(7):1104-1109. PubMed ID: 32406562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.